Famotidine in Subjects With Non-erosive Gastroesophageal Reflux Disease [clinicaltrials:NCT00141960]
Famotidine in Subjects With Non-erosive Gastroesophageal Reflux Disease [clinicaltrials:NCT00141960]
Bio2RDF identifier
NCT00141960
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00141960
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
Gastroesophageal reflux ...... bjects with non-erosive GERD.
brief title [clinicaltrials_vocabulary:brief-title]
Famotidine in Subjects With Non-erosive Gastroesophageal Reflux Disease
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2005-09-01T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
Gastrointestinal Diseases
Reflux, Gastroesophageal
Treatment effectiveness
Treatment efficacy
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2011-11-18T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00141960
official title [clinicaltrials_vocabulary:official-title]
YM1170 Phase 2/3 Study: A Doub ...... astroesophageal Reflux Disease
org study id [clinicaltrials_vocabulary:org-study-id]
1170-CL-004
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
reference [clinicaltrials_vocabulary:reference]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2005-09-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2010-06-01T00:00:00Z
identifier
clinicaltrials:NCT00141960
title
Famotidine in Subjects With Non-erosive Gastroesophageal Reflux Disease
@en
type
label
Famotidine in Subjects With No ...... e [clinicaltrials:NCT00141960]
@en